Churbz: "Please stop referring to my patience." I think
Churbz: "Please stop referring to my patience." I think I've spoken to you about "patience" once.
I think my former stock is relevant to AMBS because after languishing for what seemed an eternity, it wasn't a partnership that got it moving, it was simply revenue.
I think things will start converging for AMBS in the next few months culminating in an IPO up list in May or June, in my opinion. I think we can get to .20 cents by then without a partner...just more Lympro contracts and Lympro CLIA launch and announcement of MS launch. I think if Gerald set a date for the IPO and up list and all our revenue generators converged by June, we'd take off.
I can still see us reach .50 cents to $1.00 by year end (Pre-RS) and without a partnership. (That's a 6 to 12 bagger this year. We'll get more for a partnership or Diagnostic Division sale in 2016.
Just my honest opinions. They could be wrong, of course. But that's par for the course in a stock like this. Yes, Gerald has made some mistakes, but he's also assembled an incredible pipeline ready to explode! I've already vented my criticisms of him and have moved on to what lies before us in the immediate future. That very believable potential is making me positive rather than negative.
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Binance's New Direction Under Changpeng Zhao In the dynamic world of cryptocurrency, Binance (CRYPTO: BNB) is at a pivotal moment as co-founder Changpeng Zhao steps back into the public eye after a presidential pardon. This development marks an important chapter for Binance as it reassesses its strategy within the U.S. market, a territory it once ruled. Zhao's Vision for...
Continue Reading
DarioHealth Announces Upcoming Financial Results DarioHealth Corp. (NASDAQ: DRIO), a trailblazer in the digital health landscape, is gearing up to report its financial outcomes for the fourth quarter and full year 2024. The anticipated announcement is set to unfold prior to the market's opening on the forthcoming Monday. Details of the Conference Call Time and Access To...
Continue Reading
Luminit Inc. Expands U.S. Manufacturing Capacity Luminit Inc., known for its expertise in holographic optics, is making significant strides in expanding its manufacturing capabilities to meet the surging demand for mass production of Holographic Optical Elements (HOEs). This expansion reflects the company's commitment to the automotive, defense, and industrial sectors,...
Continue Reading
Exploring the Rise of Alternative Credentials in Education In recent years, the education landscape has experienced significant transformations, particularly in how higher education institutions approach credentialing. Alternative credentials, such as micro-credentials and digital badges, are gaining traction in response to the widening skills gap and the shifting demands...
Continue Reading
enCore Energy's Advances at Alta Mesa CPP enCore Energy (NASDAQ: EU) has achieved remarkable progress at the Alta Mesa In-Situ Recovery (ISR) Uranium Central Processing Plant (CPP). Recently, the company announced its most productive month since operations commenced, capturing over 50,000 pounds of uranium during the month. This achievement is particularly significant in...
Continue Reading